![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Impact of Pre-exposure Prophylaxis with
FTC/TDF on HIV Diagnoses, 2012-2016, United States
|
|
|
Reported by Jules Levin
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Patrick S. Sullivan,1 Dawn K. Smith,2 Robertino Mera-Giler,3 Azfar-e-Alam Siddiqi,2 Betsy Gunnels,2 Norma Harris,2 Xiaohong Hu,2 Lance Waller,1 Scott McCallister3
1Emory University School of Public Health, Atlanta, Georgia, USA; 2Centers for Disease Control and Prevention, Atlanta, Georgia, USA; 3Gilead Sciences, Inc., Foster City, California, USA
![0727181](../images%20/072718/072718-4/0727181.gif)
![0727182](../images%20/072718/072718-4/0727182.gif)
![0727183](../images%20/072718/072718-4/0727183.gif)
![0727184](../images%20/072718/072718-4/0727184.gif)
![0727185](../images%20/072718/072718-4/0727185.gif)
![0727186](../images%20/072718/072718-4/0727186.gif)
![0727187](../images%20/072718/072718-4/0727187.gif)
![0727188](../images%20/072718/072718-4/0727188.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|